Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism

Active, not recruiting

Phase 4 Results N/A

Summary of Purpose

The purpose of this study is to evaluate major adverse bleeding risks, and thromboembolic event rates post radiofrequency (RF) ablation. The primary goal is to establish safety of dabigatran use for peri-procedural anti-coagulation after left atrial catheter radiofrequency ablation, or cryoablation procedures.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 December 2015.

1 Oct 2013 29 Oct 2013 1 Dec 2015 1 Oct 2016 1 Dec 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Purpose: Supportive Care
  • Intervention: Single Group Assignment

Contacts

  • Sherry Bowman, RN

    615-875-5500